A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson’s disease : a study protocol for a randomised controlled trial
Citation
Sackley , C M , Rick , C , Au , P , Brady , M C , Beaton , G , Burton , C , Caulfield , M , Dickson , S , Dowling , F , Hughes , M , Ives , N , Jowett , S , Masterson-Algar , P , Nicoll , A , Patel , S , Smith , C H , Woolley , R & Clarke , C E 2020 , ' A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson’s disease : a study protocol for a randomised controlled trial ' , Trials , vol. 21 , no. 1 , 436 , pp. 436 . https://doi.org/10.1186/s13063-020-04354-7
Rights
This article is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.